Guido Trenn

1.5k citations
31 papers · 855 indexed · h-index 13
Topics
Monoclonal and Polyclonal Antibodies Research (6 papers)Lymphoma Diagnosis and Treatment (6 papers)Colorectal Cancer Treatments and Studies (4 papers)

In The Last Decade

Guido Trenn

30 papers receiving 831 citations

Peers

Guido Trenn
Comparison fields: 5 of 75
  • Immunology 407
  • Molecular Biology 232
  • Oncology 197
  • Pathology and Forensic Medicine 173
  • Hematology 102
Replace Alberto Bianchi with:
Alberto Bianchi Italy
Monique Sémichon France
Grazyna Wieczorek Switzerland
Lei Bi China
Anne‐Laure Mathieu France
Michal Haran Israel
Raymond Yu United States
Manuel Pérez‐Martínez Spain
Xaria X. Li Australia
Elisabeth Prager Austria
Guido Trenn relative to Alberto Bianchi Italy Alberto Bianchi's profile →
Citations per field
00.5×5.1×
Alberto Bianchi · 1×
Citations per year

Countries citing papers authored by Guido Trenn

Since Specialization
Citations

This map shows the geographic impact of Guido Trenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Trenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Trenn more than expected).

Fields of papers citing papers by Guido Trenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Trenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Trenn. The network helps show where Guido Trenn may publish in the future.

Co-authorship network of co-authors of Guido Trenn

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Trenn. A scholar is included among the top collaborators of Guido Trenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Trenn. Guido Trenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 25
4 9
5 42
6 12
7 53
8 1
9 3
10 7
11 5
12 47
13 63
14 67
15 4
16 16
17 6
18 144
19 51
20 12

About Guido Trenn

Guido Trenn is a scholar working on Physiology, Pathology and Forensic Medicine and Biological Psychiatry, having authored 31 papers that have together received 855 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Physiology (89 citations), Immunology (407 citations) and Pathology and Forensic Medicine (173 citations). Guido Trenn has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hajime Takayama, Michail V. Sitkovsky, Jane Hu‐Li, M V Sitkovsky, Jeffrey A. Bluestone, Pierre A. Henkart, W E Paul, George R. Pettit, AH Elmaagacli and DW Beelen. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026